GB2396302B - Magnetic field enhancement of tumor treatment - Google Patents
Magnetic field enhancement of tumor treatmentInfo
- Publication number
- GB2396302B GB2396302B GB0408373A GB0408373A GB2396302B GB 2396302 B GB2396302 B GB 2396302B GB 0408373 A GB0408373 A GB 0408373A GB 0408373 A GB0408373 A GB 0408373A GB 2396302 B GB2396302 B GB 2396302B
- Authority
- GB
- United Kingdom
- Prior art keywords
- magnetic field
- tumor treatment
- field enhancement
- enhancement
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
- A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
- A61N1/406—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia using implantable thermoseeds or injected particles for localized hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32808501P | 2001-10-11 | 2001-10-11 | |
US34927002P | 2002-01-18 | 2002-01-18 | |
PCT/US2002/032444 WO2003030722A2 (en) | 2001-10-11 | 2002-10-09 | Magnetic field enhancement of tumor treatment |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0408373D0 GB0408373D0 (en) | 2004-05-19 |
GB2396302A GB2396302A (en) | 2004-06-23 |
GB2396302B true GB2396302B (en) | 2006-05-31 |
Family
ID=26986208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0408373A Expired - Lifetime GB2396302B (en) | 2001-10-11 | 2002-10-09 | Magnetic field enhancement of tumor treatment |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU2002343495A1 (en) |
CA (1) | CA2463491C (en) |
GB (1) | GB2396302B (en) |
WO (1) | WO2003030722A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2855067B1 (en) | 2003-05-20 | 2005-06-24 | Emery Sa | SNOW SURF MOUNTING |
CN107362445A (en) * | 2017-08-30 | 2017-11-21 | 东北师范大学 | Anticancer targeting medicine points to electrostatic field resultant vector intensifier |
WO2019120489A1 (en) * | 2017-12-19 | 2019-06-27 | Medical Development Technologies S.A. | Heatable implant device for tumor treatment |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0039988A1 (en) * | 1980-04-29 | 1981-11-18 | Electro-Biology, Inc | Apparatus for treating an intact animal organism bearing a neoplastic process and undergoing drug treatment |
US4665898A (en) * | 1984-05-23 | 1987-05-19 | Maxwell Laboratories, Inc. | Malignancy treatment |
US5156587A (en) * | 1983-09-01 | 1992-10-20 | Montone Liber J | Method for treating malignant cells |
WO1997004830A1 (en) * | 1995-07-28 | 1997-02-13 | Gray James R | Use of a polarizing field to modify the efficacy of a bioactive agent |
US6261831B1 (en) * | 1999-03-26 | 2001-07-17 | The United States Of America As Represented By The Secretary Of The Air Force | Ultra-wide band RF-enhanced chemotherapy for cancer treatmeat |
-
2002
- 2002-10-09 AU AU2002343495A patent/AU2002343495A1/en not_active Abandoned
- 2002-10-09 WO PCT/US2002/032444 patent/WO2003030722A2/en not_active Application Discontinuation
- 2002-10-09 CA CA2463491A patent/CA2463491C/en not_active Expired - Lifetime
- 2002-10-09 GB GB0408373A patent/GB2396302B/en not_active Expired - Lifetime
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0039988A1 (en) * | 1980-04-29 | 1981-11-18 | Electro-Biology, Inc | Apparatus for treating an intact animal organism bearing a neoplastic process and undergoing drug treatment |
US5156587A (en) * | 1983-09-01 | 1992-10-20 | Montone Liber J | Method for treating malignant cells |
US4665898A (en) * | 1984-05-23 | 1987-05-19 | Maxwell Laboratories, Inc. | Malignancy treatment |
WO1997004830A1 (en) * | 1995-07-28 | 1997-02-13 | Gray James R | Use of a polarizing field to modify the efficacy of a bioactive agent |
US6261831B1 (en) * | 1999-03-26 | 2001-07-17 | The United States Of America As Represented By The Secretary Of The Air Force | Ultra-wide band RF-enhanced chemotherapy for cancer treatmeat |
Also Published As
Publication number | Publication date |
---|---|
WO2003030722A2 (en) | 2003-04-17 |
GB2396302A (en) | 2004-06-23 |
CA2463491C (en) | 2011-07-26 |
GB0408373D0 (en) | 2004-05-19 |
AU2002343495A1 (en) | 2003-04-22 |
WO2003030722A3 (en) | 2003-07-03 |
CA2463491A1 (en) | 2003-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1390096A4 (en) | Magnetic field stimulation techniques | |
GB2393202B (en) | Methods of well treatment | |
AUPR711701A0 (en) | Magnetic field therapy | |
EP1446012A4 (en) | Combination bacteriolytic therapy for the treatment of tumors | |
HUP0500424A3 (en) | Combination therapy for the treatment of cancer | |
EP1435988A4 (en) | Improved use of antitumoral compound in cancer therapy | |
EP1320376A4 (en) | Treatment of prostate cancer | |
EP1463495A4 (en) | Agents and methods for treatment of cancer | |
GB2389532C (en) | The method of treating cancer | |
PL368035A1 (en) | Compositions and methods for the treatment of cancer | |
MXPA03007036A (en) | Method of cancer therapy. | |
GB0124124D0 (en) | Methods of treatment | |
EP1389105A4 (en) | Method of treatment | |
EP1401494A4 (en) | Tumor therapy | |
AU2001280754A1 (en) | Enhancement of photodynamic therapy by anti-angiogenic treatment | |
GB2396302B (en) | Magnetic field enhancement of tumor treatment | |
EP1409734A4 (en) | Diagnosis and treatment of cancer | |
IL161630A0 (en) | Methods of treating endometreosis | |
IL161923A0 (en) | Reduction of electromagnetic radiation | |
GB0129451D0 (en) | Treatment of cancer | |
GB0115943D0 (en) | Treatment and diagosis of cancer | |
AUPR389501A0 (en) | Magnetic treatment of fluids | |
GB0008161D0 (en) | Treatment of cancer | |
GB0105097D0 (en) | Treatment of technetium | |
GB0104615D0 (en) | Treatment of technetium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE20 | Patent expired after termination of 20 years |
Expiry date: 20221008 |